- Cedric Volanti appointed as CEO of Exothera.
Exothera has announced the appointment of Cedric Volanti as its new Chief Executive Officer. Volanti, with extensive expertise in biotech, is set to lead the company into a new phase of growth.
The announcement was made on July 18, 2024, with Volanti expected to build on Exothera’s existing strengths. His leadership aims to support the company’s goal of transforming biotech drug manufacturing to improve access to advanced therapies globally.
Thibault Jonckheere will serve as Deputy CEO, working closely with Volanti this summer to refine strategic priorities and drive growth and innovation in the biopharmaceutical industry.
Volanti’s appointment is seen as a strategic move to enhance Exothera’s position in the contract manufacturing sector. “I am excited to join Exothera and look forward to working with the team to achieve our ambitious goals,” Volanti stated.
